Epidemiological factors influencing the emergence of antimicrobial resistance

M L Cohen1

  • 1Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.

Ciba Foundation Symposium
|January 1, 1997
PubMed

Insights

Antimicrobial resistance is a growing global health threat, impacting both hospitals and communities. Addressing this requires better surveillance, responsible drug use, new treatments, and improved infection control to combat drug-resistant pathogens.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Microbiology

Background:

  • Antimicrobial resistance (AMR) poses a significant public health challenge, affecting both hospital-acquired and community-acquired infections.
  • Drug-resistant pathogens like Staphylococcus aureus, Mycobacterium tuberculosis, enterococci, and Gram-negative rods increase morbidity, mortality, and healthcare costs due to prolonged hospital stays and expensive treatments.
  • Drug-resistant community-acquired infections caused by pathogens such as Salmonella, Shigella, Neisseria gonorrhoeae, Haemophilus influenzae, and Streptococcus pneumoniae are prevalent globally.

Purpose of the Study:

  • To highlight the growing public health problem of antimicrobial resistance.
  • To identify the contributing factors to the emergence of antimicrobial resistance.
  • To propose strategies for addressing antimicrobial resistance and its associated challenges.

Main Methods:

  • This study is a review and synthesis of current knowledge on antimicrobial resistance.
  • It examines the impact of resistant pathogens in both hospital and community settings.
  • It analyzes the societal, technological, environmental, and microbial factors contributing to AMR.

Main Results:

  • Antimicrobial resistance leads to increased illness, death, and healthcare expenses.
  • Factors contributing to AMR include susceptible populations, global travel, technological changes, microbial adaptation, and weakened public health measures.
  • Specific drug-resistant pathogens are causing significant infections worldwide.

Conclusions:

  • Combating antimicrobial resistance necessitates a multi-faceted approach.
  • Key strategies include enhanced surveillance, prudent antimicrobial drug use, development of novel antimicrobial agents, and robust infection control practices.
  • Improved vaccination programs and effective disease control are also crucial for managing antimicrobial resistance.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...